Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 9/24/2024 | $65.00 → $75.00 | Market Perform → Outperform | BMO Capital Markets |
| 9/5/2024 | $76.00 | Overweight | Barclays |
| 7/11/2024 | $58.00 → $60.00 | Overweight → Equal Weight | Wells Fargo |
| 5/22/2024 | $67.00 | Buy | BofA Securities |
| 5/6/2024 | Outperform → Peer Perform | Wolfe Research | |
| 11/20/2023 | $57.00 → $53.00 | Buy → Neutral | Goldman |
| 10/30/2023 | Outperform → Market Perform | BMO Capital Markets | |
| 9/22/2023 | $59.00 | Outperform | Wolfe Research |
4 - RYAN SPECIALTY HOLDINGS, INC. (0001849253) (Issuer)
3 - RYAN SPECIALTY HOLDINGS, INC. (0001849253) (Issuer)
4 - RYAN SPECIALTY HOLDINGS, INC. (0001849253) (Issuer)
4 - RYAN SPECIALTY HOLDINGS, INC. (0001849253) (Issuer)
Ryan Specialty (NYSE:RYAN), a leading international specialty insurance services firm, has completed the acquisition of Innovisk Capital Partners ("Innovisk") from Abry Partners ("Abry") and BHMS Investments, LP ("BHMS"). Innovisk is a part of Ryan Specialty Underwriting Managers ("RSUM"), the underwriting management segment within Ryan Specialty. The acquisition was previously announced on October 30, 2024 and can be found here. About Ryan Specialty Founded in 2010, Ryan Specialty is a service provider of specialty products and solutions for insurance brokers, agents and carriers. Ryan Specialty provides distribution, underwriting, product development, administration and risk management
Ryan Specialty Holdings, Inc. (NYSE:RYAN) ("Ryan Specialty"), a leading international specialty insurance firm, today announced it will release its Third Quarter 2024 financial results after the market closes on Wednesday, October 30, 2024. Ryan Specialty will hold a conference call to discuss the financial results at 5:00pm Eastern Time on October 30, 2024. A live webcast of the conference call will be available on Ryan Specialty's investor relations website at ir.ryanspecialty.com. The dial-in number for the conference call is (877) 451-6152 (toll-free) or (201) 389-0879 (international). Please dial the number 10 minutes prior to the scheduled start time. A webcast replay of the call wi
Ryan Specialty (NYSE:RYAN), a leading international specialty insurance services firm, is pleased to announce that on October 1, 2024 it completed the acquisition of certain assets of the European managing general agent, Geo Underwriting Europe BV ("Geo Europe"), part of The Ardonagh Group. Geo Europe is based in Rotterdam, Netherlands, with operations in Germany and specializes in Financial Lines. Geo Europe will join the Ryan Financial Lines ("RFL") unit within the Ryan Specialty Underwriting Managers division of Ryan Specialty, complementing RFL's European expansion objectives. The acquisition was previously announced on September 3, 2024 and can be found here. About Ryan Specialty Fou
Ryan Specialty (NYSE:RYAN), a leading international specialty insurance services firm, has completed the acquisition of Innovisk Capital Partners ("Innovisk") from Abry Partners ("Abry") and BHMS Investments, LP ("BHMS"). Innovisk is a part of Ryan Specialty Underwriting Managers ("RSUM"), the underwriting management segment within Ryan Specialty. The acquisition was previously announced on October 30, 2024 and can be found here. About Ryan Specialty Founded in 2010, Ryan Specialty is a service provider of specialty products and solutions for insurance brokers, agents and carriers. Ryan Specialty provides distribution, underwriting, product development, administration and risk management
BOSTON and WESTPORT, Conn., Nov. 4, 2024 /PRNewswire/ -- Abry Partners, a Boston-based private equity firm, and BHMS Investments, LP, a Connecticut-based private equity firm, have completed the sale of Innovisk to Ryan Specialty (NYSE:RYAN), a leading international specialty insurance services firm. Innovisk was founded in 2017 and consists of a diverse, non-correlated portfolio of seven highly regarded specialty MGUs. Innovisk's lines of business include environmental, transactional liability, U.S. and international financial lines, professional liability for lawyers, commercial auto liability, and UK professional indemnity and P&C. Headquartered in London, Innovisk also has offices in the
- Total Revenue grew 20.5% year-over-year to $604.7 million - - Organic Revenue Growth Rate* of 11.8% year-over-year - - Net Income of $28.6 million, or $0.09 per diluted share - - Adjusted EBITDAC* grew 29.4% year-over-year to $190.3 million - - Adjusted Net Income increased 31.2% year-over-year to $113.6 million, or $0.41 per diluted share - Ryan Specialty Holdings, Inc. (NYSE:RYAN) ("Ryan Specialty" or the "Company"), a leading international specialty insurance firm, today announced results for the third quarter ended September 30, 2024. Third Quarter 2024 Highlights Revenue grew 20.5% year-over-year to $604.7 million, compared to $501.9 million in the prior-year period Organic
SC 13G/A - RYAN SPECIALTY HOLDINGS, INC. (0001849253) (Subject)
SC 13G - RYAN SPECIALTY HOLDINGS, INC. (0001849253) (Subject)
SC 13D/A - RYAN SPECIALTY HOLDINGS, INC. (0001849253) (Subject)
BOSTON and WESTPORT, Conn., Nov. 4, 2024 /PRNewswire/ -- Abry Partners, a Boston-based private equity firm, and BHMS Investments, LP, a Connecticut-based private equity firm, have completed the sale of Innovisk to Ryan Specialty (NYSE:RYAN), a leading international specialty insurance services firm. Innovisk was founded in 2017 and consists of a diverse, non-correlated portfolio of seven highly regarded specialty MGUs. Innovisk's lines of business include environmental, transactional liability, U.S. and international financial lines, professional liability for lawyers, commercial auto liability, and UK professional indemnity and P&C. Headquartered in London, Innovisk also has offices in the
Ryan Specialty (NYSE:RYAN), a leading international specialty insurance services firm, is in final discussions to acquire Innovisk Capital Partners ("Innovisk") from Abry Partners ("Abry") and BHMS Investments, LP ("BHMS"). As a result of the acquisition, Innovisk would become a part of Ryan Specialty Underwriting Managers ("RSUM"), the underwriting management segment within Ryan Specialty. The acquisition is expected to close early next month. Innovisk was founded in 2017 and consists of a diverse, non-correlated portfolio of seven highly regarded specialty MGUs. Innovisk's lines of business include environmental, transactional liability, US and international financial lines, professional
Ryan Specialty (NYSE:RYAN), a leading international specialty insurance firm, is pleased to announce that today it has completed the acquisition of certain assets of EverSports & Entertainment Insurance, Inc. ("EverSports") from the Everest Group, Ltd. (NYSE:EG) group of companies. EverSports is a managing general underwriter focused on sports, leisure and entertainment ("SLE") risks and is based in Carmel, Indiana. Founded in 2013, EverSports is a leader in the SLE insurance industry with broad diversification across the various SLE sub-classes (amusement facilities, amateur sports, touring artists, etc.). The relevant business will join Alive Risk, Ryan Specialty's existing SLE facility,
Citigroup analyst Michael Ward maintains Ryan Specialty Hldgs (NYSE:RYAN) with a Neutral and raises the price target from $56 to $62.
JP Morgan analyst Jimmy Bhullar maintains Ryan Specialty Hldgs (NYSE:RYAN) with a Underweight and raises the price target from $49 to $54.
Wells Fargo analyst Elyse Greenspan downgrades Ryan Specialty Hldgs (NYSE:RYAN) from Overweight to Equal-Weight and raises the price target from $58 to $60.
10-Q - RYAN SPECIALTY HOLDINGS, INC. (0001849253) (Filer)
8-K - RYAN SPECIALTY HOLDINGS, INC. (0001849253) (Filer)
8-K - RYAN SPECIALTY HOLDINGS, INC. (0001849253) (Filer)
BMO Capital Markets upgraded Ryan Specialty Group from Market Perform to Outperform and set a new price target of $75.00 from $65.00 previously
Barclays initiated coverage of Ryan Specialty Group with a rating of Overweight and set a new price target of $76.00
Wells Fargo downgraded Ryan Specialty Group from Overweight to Equal Weight and set a new price target of $60.00 from $58.00 previously